Advertisement
Illumina, Inc.

Illumina, Inc. (ILMN) Stock Overview

Explore Illumina, Inc.โ€™s financial performance, market position, analyst ratings, and future outlook.

ILMNโ—NASDAQ
HealthcareMedical - Diagnostics & Research
$165.25
$7.21(4.56%)
U.S. Market is Open ยท 11:55
Advertisement

Illumina, Inc. (ILMN)

Meyka AI Score

Z

Key Financials

Market Cap24.2B
P/E Ratio28.75
EPS (TTM)$5.50
ROE0.34%
Fundamental Analysis

AI Price Forecasts

1 Month$156.02
3 Months$115.10
1 Year Target$89.80

ILMN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Illumina, Inc. (ILMN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.23, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $89.80.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 28.75 and a market capitalization of 24.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.26%
5-Day Change
-6.85%
1-Month Change
12.79%
3-Month Change
28.77%
6-Month Change
21.12%
Year-to-Date (YTD) Change
22.01%
1-Year Change
88.31%
3-Year Change
-17.88%
5-Year Change
-62.05%
All-Time (Max) Change
740.94%

Contact Information

858 202 4500
5200 Illumina Way, San Diego, CA, 92122

Company Facts

8,970 Employees
IPO DateJul 28, 2000
CountryUS
Actively Trading

Frequently Asked Questions